GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $392,000 | 0.0% | 9,000 | 0.0% | 0.01% | +42.9% |
| Q1 2022 | $392,000 | -1.3% | 9,000 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $397,000 | +15.4% | 9,000 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $344,000 | -3.9% | 9,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $358,000 | +11.5% | 9,000 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $321,000 | +36.6% | 9,000 | +40.7% | 0.01% | 0.0% |
| Q4 2020 | $235,000 | +231.0% | 6,395 | +237.5% | 0.01% | +100.0% |
| Q3 2020 | $71,000 | +24.6% | 1,895 | +35.8% | 0.00% | 0.0% |
| Q2 2020 | $57,000 | +7.5% | 1,395 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $53,000 | +178.9% | 1,395 | +253.2% | 0.01% | +400.0% |
| Q4 2019 | $19,000 | +11.8% | 395 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $17,000 | +6.2% | 395 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $16,000 | -99.4% | 395 | -99.4% | 0.00% | -90.9% |
| Q2 2016 | $2,799,000 | +1047.1% | 64,600 | +1002.6% | 0.01% | +1000.0% |
| Q2 2015 | $244,000 | +23.2% | 5,859 | +36.4% | 0.00% | 0.0% |
| Q1 2015 | $198,000 | -66.4% | 4,296 | -69.4% | 0.00% | -66.7% |
| Q4 2014 | $590,000 | – | 14,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |